STTK

Shattuck Labs (STTK)

About Shattuck Labs (STTK)

Shattuck Labs, Inc. is a biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Details

Daily high

$6.86

Daily low

$6.30

Price at open

$6.37

52 Week High

$8.33

52 Week Low

$0.71

Market cap

517.7M

Dividend yield

0.00%

Volume

1.6M

Avg. volume

503,304

P/E ratio

-10.76

Shattuck Labs News